Catherine Dugast
Overview
Explore the profile of Catherine Dugast including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
818
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Castera L, Krieger S, Rousselin A, Legros A, Baumann J, Bruet O, et al.
Eur J Hum Genet
. 2014 Feb;
22(11):1305-13.
PMID: 24549055
To optimize the molecular diagnosis of hereditary breast and ovarian cancer (HBOC), we developed a next-generation sequencing (NGS)-based screening based on the capture of a panel of genes involved, or...
12.
Bubien V, Bonnet F, Brouste V, Hoppe S, Barouk-Simonet E, David A, et al.
J Med Genet
. 2013 Jan;
50(4):255-63.
PMID: 23335809
Background: PTEN hamartoma tumour syndrome (PHTS) encompasses several clinical syndromes with germline mutations in the PTEN tumour suppressor gene, including Cowden syndrome which is characterised by an increased risk of...
13.
Lecarpentier J, Nogues C, Mouret-Fourme E, Gauthier-Villars M, Lasset C, Fricker J, et al.
Breast Cancer Res
. 2012 Jul;
14(4):R99.
PMID: 22762150
Introduction: Mutations in BRCA1 and BRCA2 confer a high risk of breast cancer (BC), but the magnitude of this risk seems to vary according to the study and various factors....
14.
Pujol P, Lasset C, Berthet P, Dugast C, Delaloge S, Fricker J, et al.
Fam Cancer
. 2011 Nov;
11(1):77-84.
PMID: 22076253
Women with germline BRCA1 or BRCA2 (BRCA1/2) mutations are considered as an extreme risk population for developing breast cancer. Prophylactic mastectomy provides a valid option to reduce such risk, impacting...
15.
Bertolotto C, Lesueur F, Giuliano S, Strub T, de Lichy M, Bille K, et al.
Nature
. 2011 Oct;
480(7375):94-8.
PMID: 22012259
So far, no common environmental and/or phenotypic factor has been associated with melanoma and renal cell carcinoma (RCC). The known risk factors for melanoma include sun exposure, pigmentation and nevus...
16.
El Abed R, Bourdon V, Voskoboinik I, Omri H, Ben Youssef Y, Laatiri M, et al.
Hered Cancer Clin Pract
. 2011 Sep;
9(1):9.
PMID: 21936944
Perforin gene (PRF1) mutations have been identified in some patients diagnosed with the familial form of hemophagocytic lymphohistiocytosis (HLH) and in patients with lymphoma. The aim of the present study...
17.
Gardie B, Remenieras A, Kattygnarath D, Bombled J, Lefevre S, Perrier-Trudova V, et al.
J Med Genet
. 2011 Mar;
48(4):226-34.
PMID: 21398687
Background: Hereditary leiomyomatosis and renal cell cancer (HLRCC) is an autosomal dominant disorder predisposing humans to cutaneous and uterine leiomyomas; in 20% of affected families, type 2 papillary renal cell...
18.
Banneau G, Guedj M, MacGrogan G, de Mascarel I, Velasco V, Schiappa R, et al.
Breast Cancer Res
. 2010 Aug;
12(4):R63.
PMID: 20712882
Introduction: Breast carcinoma is the main malignant tumor occurring in patients with Cowden disease, a cancer-prone syndrome caused by germline mutation of the tumor suppressor gene PTEN characterized by the...
19.
Reggoug S, Ropert A, Blayau M, Zeddini A, Dugast C, Pequin P, et al.
Am J Gastroenterol
. 2009 Oct;
104(10):2648-9.
PMID: 19806110
No abstract available.
20.
Tinat J, Bougeard G, Baert-Desurmont S, Vasseur S, Martin C, Bouvignies E, et al.
J Clin Oncol
. 2009 Aug;
27(26):e108-9.
PMID: 19652052
No abstract available.